BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee IH, Kang K, Kang BW, Lee SJ, Bae WK, Hwang JE, Kim HJ, Park SY, Park JS, Choi GS, Kim JG. Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Med Oncol 2018;35:145. [PMID: 30206710 DOI: 10.1007/s12032-018-1202-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Takenaka IKTM, Bartelli TF, Defelicibus A, Sendoya JM, Golubicki M, Robbio J, Serpa MS, Branco GP, Santos LBC, Claro LCL, Dos Santos GO, Kupper BEC, da Silva IT, Llera AS, de Mello CAL, Riechelmann RP, Dias-Neto E, Iseas S, Aguiar S, Nunes DN. Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer. Front Oncol 2022;12:809441. [PMID: 35392220 DOI: 10.3389/fonc.2022.809441] [Reference Citation Analysis]
2 Liu H, Wei R, Li C, Zhao Z, Guan X, Yang M, Liu Z, Wang X, Jiang Z. BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy. Cancer Manag Res 2020;12:10321-32. [PMID: 33116887 DOI: 10.2147/CMAR.S268928] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yuan Y, Li L, Cheng Q, Diao F, Zeng Q, Yang X, Wu Y, Zhang H, Huang M, Chen J, Zhou Q, Zhu Y, Hua R, Tian J, Wang X, Zhou Z, Hao J, Yu J, Hua D, Liu J, Guo X, Zhou Q, Sha J. In vitro testicular organogenesis from human fetal gonads produces fertilization-competent spermatids. Cell Res 2020;30:244-55. [PMID: 32086476 DOI: 10.1038/s41422-020-0283-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 De Mattia E, Roncato R, Palazzari E, Toffoli G, Cecchin E. Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Front Pharmacol 2020;11:897. [PMID: 32625092 DOI: 10.3389/fphar.2020.00897] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun Y, Zhang Y, Wu X, Chi P. A Four Gene-Based Risk Score System Associated with Chemoradiotherapy Response and Tumor Recurrence in Rectal Cancer by Co-Expression Network Analysis. Onco Targets Ther. 2020;13:6721-6733. [PMID: 32753901 DOI: 10.2147/ott.s256696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Nikolic A, Krivokapic Z. Nucleic acid-based markers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Surg Oncol 2022;41:101743. [PMID: 35358913 DOI: 10.1016/j.suronc.2022.101743] [Reference Citation Analysis]
7 Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Felsani A, Tringali G, Cifola I, Pozzoli G, Cenciarelli C. Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene. Cancer Cell Int 2022;22:9. [PMID: 34996478 DOI: 10.1186/s12935-021-02419-4] [Reference Citation Analysis]
8 Xiao WW, Li M, Guo ZW, Zhang R, Xi SY, Zhang XG, Li Y, Wu DQ, Ren YF, Pang XL, Wan XB, Li K, Zhou CL, Zhai XM, Liang ZK, Wang QX, Zeng ZF, Zhang HZ, Yang XX, Wu YS, Li M, Gao YH. A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 2021;110:482-91. [PMID: 33434612 DOI: 10.1016/j.ijrobp.2021.01.005] [Reference Citation Analysis]
9 Del Bufalo D, Di Martile M, Valentini E, Manni I, Masi I, D'amore A, Filippini A, Nicoletti C, Zaccarini M, Cota C, Castro MV, Quezada MJ, Rosanò L, Lopez-bergami P, D'aguanno S. Bcl-2-like protein-10 increases aggressive features of melanoma cells. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2022.00068] [Reference Citation Analysis]